Home
Mail
News
Sport
Finance
Celebrity
Style
Weather
Mobile
Messenger
Movies
More
Yahoo
Mail
News
Market Data
Crypto
Bank of England
Money Matters
Property
Top Stocks
Work & Management
Industry News
Brexit
My Portfolio
My Screeners
Watchlists
Videos
UK markets open in 9 minutes
NIKKEI 225
38,179.46
-49.65
(-0.13%)
HANG SENG
19,066.21
+102.53
(+0.54%)
CRUDE OIL
78.15
-0.11
(-0.14%)
GOLD FUTURES
2,356.70
-18.30
(-0.77%)
DOW
39,512.84
+837.14
(+2.16%)
Bitcoin GBP
48,992.12
+351.62
(+0.72%)
Zevra Therapeutics, Inc. (ZVRA)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
4.8200
-0.2100
(-4.17%)
At close: 04:00PM EDT
5.0500
+0.23
(+4.77%)
After hours:
04:01PM EDT
Summary
Chart
Conversations
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
16,563
-
10,161
28,650
13,288
Cost of revenue
1,089
-
222
2,059
1,305
Gross profit
15,474
-
9,939
26,591
11,983
Operating expenses
Research development
34,926
-
19,803
10,161
8,843
Selling general and administrative
24,734
-
15,038
8,701
7,921
Total operating expenses
59,660
-
34,841
18,862
16,764
Operating income or loss
-44,186
-
-24,902
7,729
-4,781
Interest expense
915
-
335
376
7,090
Total other income/expenses net
541
-
-3,081
-16,135
-1,012
Income before tax
-39,951
-
-26,805
-8,521
-12,794
Income tax expense
-34
-
-33
34
-34
Income from continuing operations
-39,917
-
-26,772
-8,555
-12,760
Net income
-39,917
-
-26,772
-8,555
-12,760
Net income available to common shareholders
-39,917
-
-26,772
-62,897
-12,760
Basic EPS
-1.16
-1.30
-0.78
-2.11
-3.21
Diluted EPS
-1.16
-1.30
-0.78
-2.11
-3.21
Basic average shares
34,400
35,452
34,489
29,766
3,981
Diluted average shares
36,212
35,452
34,489
29,766
3,981
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.